Australian Clinical Labs Ltd
ASX:ACL
Balance Sheet
Balance Sheet Decomposition
Australian Clinical Labs Ltd
Current Assets | 125.8m |
Cash & Short-Term Investments | 25.6m |
Receivables | 74.1m |
Other Current Assets | 26m |
Non-Current Assets | 458m |
Long-Term Investments | 1.9m |
PP&E | 281.2m |
Intangibles | 165.1m |
Other Non-Current Assets | 9.9m |
Current Liabilities | 190m |
Accounts Payable | 41.2m |
Other Current Liabilities | 148.7m |
Non-Current Liabilities | 228.9m |
Long-Term Debt | 225.3m |
Other Non-Current Liabilities | 3.6m |
Balance Sheet
Australian Clinical Labs Ltd
Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
7
|
7
|
4
|
35
|
35
|
26
|
20
|
|
Cash Equivalents |
7
|
7
|
4
|
35
|
35
|
26
|
20
|
|
Short-Term Investments |
0
|
3
|
1
|
0
|
1
|
1
|
1
|
|
Total Receivables |
41
|
41
|
46
|
63
|
63
|
91
|
75
|
|
Accounts Receivables |
29
|
33
|
45
|
62
|
62
|
87
|
70
|
|
Other Receivables |
11
|
9
|
2
|
1
|
1
|
4
|
5
|
|
Inventory |
8
|
7
|
10
|
10
|
13
|
20
|
15
|
|
Other Current Assets |
3
|
3
|
4
|
3
|
5
|
4
|
5
|
|
Total Current Assets |
58
|
61
|
65
|
112
|
117
|
143
|
116
|
|
PP&E Net |
38
|
34
|
42
|
194
|
238
|
310
|
288
|
|
PP&E Gross |
38
|
34
|
42
|
194
|
238
|
310
|
288
|
|
Accumulated Depreciation |
56
|
61
|
75
|
152
|
237
|
341
|
117
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
7
|
7
|
6
|
|
Goodwill |
13
|
13
|
36
|
36
|
106
|
159
|
159
|
|
Long-Term Investments |
0
|
1
|
0
|
1
|
0
|
0
|
1
|
|
Other Long-Term Assets |
12
|
10
|
11
|
23
|
16
|
9
|
8
|
|
Other Assets |
13
|
13
|
36
|
36
|
106
|
159
|
159
|
|
Total Assets |
121
N/A
|
119
-2%
|
154
+29%
|
366
+138%
|
484
+32%
|
628
+30%
|
579
-8%
|
|
Liabilities | ||||||||
Accounts Payable |
7
|
9
|
12
|
13
|
19
|
26
|
18
|
|
Accrued Liabilities |
30
|
31
|
37
|
37
|
43
|
46
|
44
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
1
|
0
|
63
|
70
|
95
|
101
|
|
Other Current Liabilities |
16
|
16
|
17
|
23
|
34
|
58
|
25
|
|
Total Current Liabilities |
54
|
57
|
66
|
135
|
166
|
225
|
188
|
|
Long-Term Debt |
48
|
52
|
56
|
158
|
234
|
168
|
215
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
4
|
4
|
4
|
4
|
3
|
3
|
3
|
|
Total Liabilities |
107
N/A
|
114
+6%
|
126
+11%
|
297
+135%
|
402
+35%
|
396
-2%
|
406
+3%
|
|
Equity | ||||||||
Common Stock |
239
|
239
|
147
|
147
|
798
|
798
|
798
|
|
Retained Earnings |
224
|
233
|
119
|
78
|
716
|
561
|
620
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
5
|
6
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
14
N/A
|
5
-61%
|
27
+402%
|
69
+152%
|
82
+19%
|
232
+184%
|
172
-26%
|
|
Total Liabilities & Equity |
121
N/A
|
119
-2%
|
154
+29%
|
366
+138%
|
484
+32%
|
628
+30%
|
579
-8%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
202
|
202
|
202
|
202
|
202
|
202
|
201
|